Clinical Trial Update: Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 trial evaluating the safety and efficacy of MTX101 for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MTX101 2mg

Snippet

Sponsor: Manistee Therapeutics | Conditions: Migraine | Phase 2 | Status: COMPLETED